Corin wins FDA nod for Unity Knee tibial insert for robot-assisted TKA
October 4, 2024
Corin announced that it received FDA 510(k) clearance for its Unity Knee medial constrained (MC) tibial insert.
Corin announced that it received FDA 510(k) clearance for its Unity Knee medial constrained (MC) tibial insert.
Pi-Cardia designed the Shortcut device to mitigate the risk of coronary artery obstruction by splitting aortic valve leaflets before valve placement.
GE HealthCare’s MIM Software today announced it received FDA 510(k) clearance for Monte Carlo dosimetry.
IRVINE, Calif., Oct. 3, 2024 /PRNewswire/ — OrthAlign, Inc., a privately held medical device company, announces FDA 510(k) clearance of their Lantern Hip handheld technology for direct anterior total hip arthroplasty with the patient in the supine position. Lantern Hip is the latest addition to the Lantern platform, joining existing applications for total knee, revision knee, and partial knee arthroplasty.
The company says this is the first and only software validated on ground-truth histology, the gold standard for plaque characterisation according to the company.
SetPoint Medical today announced FDA Investigational Device Exemption approval to study its proprietary neuroimmune modulation platform for people with relapsing-remitting multiple sclerosis.
AtriCure (Nasdaq: ATRC)+
announced that it received CE mark for the EnCompass clamp for cardiac tissue ablation procedures.
BioIntelliSense announced today that it received FDA clearance for its rechargeable BioButton multi-patient wearable and BioDashboard system.
The 3D capabilities are part of Siemens’ first completely redesigned mammography platform in over a decade.
Qnovia announced that the FDA cleared its investigational new drug (IND) application for the RespiRx smoking cessation inhaler (QN-01).